510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

DL900 Series Holter Recorder

K071733510(k) SpecialCleared Jul 24, 200728-day reviewClass II21 CFR 870.2800Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Braemar, Inc. · MWJ Electrocardiograph, Ambulatory (Without Analysis)

Cleared on Jul 24, 2007 after a 28-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 2 later devices descend from it. It has been recalled 3 times.

Decided
Jul 24, 2007
Review
28 days
Class
Class II
Product code
MWJ
Recalls
3
Predicates
0

2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2011: 1 descendant cleared20052010201520202025
  1. This deviceK071733 DL900 Series Holter RecorderBraemar, Inc. · 2007
  2. Descendant · cites it directly · 0 of its ownK130294 Braemar Cardiokey Holter RecorderBraemar Manufacturing, LLC · 2013
  3. Descendant · cites it directly · 0 of its ownK101969 MH1 Microholter RecorderExelys, LLC · 2011

Most influential descendants

Showing 2 of 2 · See all
  • K130294Braemar Cardiokey Holter RecorderBraemar Manufacturing, LLC · 2013 · cites it directly0descendants
  • K101969MH1 Microholter RecorderExelys, LLC · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K071733DL900 Series Holter RecorderBraemar, Inc.2007—
+1K130294Braemar Cardiokey Holter RecorderBraemar Manufacturing, LLC2013—
+1K101969MH1 Microholter RecorderExelys, LLC2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201310
FIG. 1 — Lineage of K071733, 2007–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MWJ device

  1. #1 K254119 Wearable ECG Recorder (YMHeart XY-12)…score 14.1 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K130294Braemar Cardiokey Holter RecorderBraemar Manufacturing, LLC20130
K101969MH1 Microholter RecorderExelys, LLC20110

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 22, 2020Class IIZ-1460-2020Software designAn issue with the DL900 and DL950 Series Holter Recorder was recognized on January 1, 2020. This issue can prevent the recorder from operating normally. Braemar confirmed that beginning on January 1, 2020 if a AAA battery is inserted in…
Jan 22, 2020Class IIZ-1459-2020Software designAn issue with the DL900 and DL950 Series Holter Recorder was recognized on January 1, 2020. This issue can prevent the recorder from operating normally. Braemar confirmed that beginning on January 1, 2020 if a AAA battery is inserted in…
Jan 13, 2020Class IIZ-1345-2020Device Designif an AAA battery is inserted in the recorder and a user attempts to start it, or if the recorder is inserted in the docking station, the recorder will display Error: 602 and fail to function for a new patient study.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K130294 (Braemar Manufacturing, LLC, 2013) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MWJ devices

MWJ Electrocardiograph, Ambulatory (Without Analysis): FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · MWJ

2in 2024

2007: 52008: 12009: 22010: 32011: 32012: 12013: 32014: 22016: 22018: 12021: 12022: 42024: 22026 (partial year): 5
2007high 5 (2007) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MWJ

337in 2022

2007: 142 days median2010: 90 days median2011: 206 days median2013: 241 days median2022: 337 days median2026 (partial year): 270 days median
2007high 337 (2022) · low 90 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MWJ

2in 2024

2024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MWJ

8in 2025

2009: 52012: 22013: 42014: 12015: 12016: 12017: 22018: 12019: 42020: 122021: 32022: 62023: 52024: 32025: 8
2007high 12 (2020) · low 0 (2007)2025

MAUDE reports naming product code MWJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007514200
20081—00
20092—05
201039000
2011320600
20121—02
2013324104
20142—01
20150—01
20162—01
20170—02
20181—01
20190—04
20200—012
20211—03
2022433706
20230—05
20242—23
20250—08
202652700—

What is it indicated for?

The DL900 Series Hotter Recorder is intended for patients requiring ambulatory (Holter) monitoring. Such monitoring is most frequently used for the indications below: 1. Evaluation of symptoms suggesting arrhythmia or myocardial ischemia. 2. Evaluation of ECG documenting therapeutic interventions in individual patients or groups of patients. 3. Evaluation of patients for ST segment changes. 4. Evaluation of a patient's response after resuming…

Read the full statement (99 words)

The DL900 Series Hotter Recorder is intended for patients requiring ambulatory (Holter)

monitoring. Such monitoring is most frequently used for the indications below:

1. Evaluation of symptoms suggesting arrhythmia or myocardial ischemia.

2. Evaluation of ECG documenting therapeutic interventions in individual patients or

groups of patients.

3. Evaluation of patients for ST segment changes.

4. Evaluation of a patient's response after resuming occupational or recreational

activities (e.g., after M.I. or cardiac surgery.)

5. Clinical and epidemiological research studies.

6. Evaluation of patients with pacemakers.

7. Reporting of time and frequency domain heart rate variability.

8. Reporting of QT Interval

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K071733: DL900 Series Holter Recorder.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071733

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026